The slip
PARKINSON RECEIPTno. 12593
28 Oct 2026, 02:53 UTCdopamine neurons, braak
predictionPC in dopamine neurons tracks Braak Lewy-body stage
registered99419b88245a2155
discovery-0.33 p=0.383 n=9
replication-0.21 p=0.591 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.33, p 0.383)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTd43fd225a716e98d8400294a…
follows 243b50f4df26…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 12593: PC in dopamine neurons, braak
- power
- full sample -0.27 (p 0.281, n 18), 95% CI -0.65 to +0.23. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.29 (p 0.239, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.34 (p 0.173, n 18). could be the mix.
- skeptic
- leave-one-out range -0.40 to -0.18, sign flips 0; without severely affected donors -0.27 (p 0.281, n 18). fragile.
- cell type
- strongest in oligodendrocytes: -0.74 (p 4.4e-4, n 18) vs -0.27 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for PC in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up PC · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.02 p 0.929 (needs p < 1.8e-4)